"Ipratropium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
| Descriptor ID |
D009241
|
| MeSH Number(s) |
D02.145.074.722.229.400 D03.132.760.180.572.400 D03.132.889.180.648.400 D03.605.084.500.722.229.400 D03.605.869.229.400
|
| Concept/Terms |
Ipratropium- Ipratropium
- (endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
- N-Isopropylatropine
- N Isopropylatropine
Ipratropium Bromide- Ipratropium Bromide
- Ipratropium Bromide Monohydrate
- Bromide Monohydrate, Ipratropium
- Monohydrate, Ipratropium Bromide
|
Below are MeSH descriptors whose meaning is more general than "Ipratropium".
Below are MeSH descriptors whose meaning is more specific than "Ipratropium".
This graph shows the total number of publications written about "Ipratropium" by people in this website by year, and whether "Ipratropium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ipratropium" by people in Profiles.
-
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6.
-
Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2009 Dec; 22(6):587-92.
-
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Ther Adv Respir Dis. 2008 Apr; 2(2):37-48.
-
Ipratropium-bromide-induced acute anisocoria in the intensive care setting due to ill-fitting face masks. Respir Care. 2005 Dec; 50(12):1662-4.
-
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.
-
The effect of heliox-driven bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. J Asthma. 2002 Oct; 39(7):659-65.